The FDA has approved a new drug from Eli Lilly to help Americans lose weight: Zepbound. The drug is a new formula of the popular diabetes treatment Mounjaro and it joins other medications like Ozempic and Wegovy as weapons against obesity. Emergency medicine physician Dr. Owais Durrani joined CBS News to discuss the new drug and its potential side effects.
Source: CBS Minnesota
FDA approves weight loss drug Zepbound, joining Ozempic and Wegovy in market
Published in Fifty Lakes
More from Fifty LakesMore posts in Fifty Lakes »
- Hegseth deflects direct involvement in Sept. 2 boat strike orders, praises Admiral Bradley
- Trump says "affordability" is con job during Cabinet meeting, Hegseth touts lethal boat strikes
- Hegseth defends deadly boat strikes near Venezuela during Cabinet meeting: "We've only just begun"
- Watch Live: Trump holds final Cabinet meeting of the year at White House
- 11/24: Face the Nation
Be First to Comment